Find Medicine

Jakavi 15

جاكافي 15 | Chemotherapeutics and Drugs Affecting Immunoresponse
Jakavi 15

Drug Category

Immune system

Medicinal form

Tablets

Active ingredient

Ruxolitinib

Concentration

15mg

Manufacturer

Novartis

Price

36545 EGP

Uses

is an oral inhibitor of the JAK 1 and JAK 2 tyrosine kinases. For the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea and for the treatment of diseaserelated splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idio pathic myelofibrosis), post polycythemia vera myelofi

Note: The information provided about this drug does not substitute for consulting a doctor.

Jakavi 15

The doctor answers your questions quickly

Are you experiencing any symptoms at the moment? Now many specialist doctors are ready to help you.

Calculators

Calculator for Health is a very useful tool to help individuals better understand and manage their health. By providing measurable data, users can make better informed decisions to maintain or improve their well-being.

See list pharmacies

Direct Access to Pharmacy Through Innovative Portal

Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips

See list pharmacies